Stock Rich List
#8733 on the rich list of 14,644 insiders

James M. Frates

Chief Financial Officer at Amylyx Pharmaceuticals. Based in Cambridge, Massachusetts.

$10.1M
in disclosed stock, −$162K (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
8733rd of 14,644
Companies held
1
Largest holding
AMLX, 100.0% of total
Latest SEC filing
Nov 10, 2026

What the $10.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Amylyx Pharmaceuticals AMLX
Common Stock
Directly233,625$26.20$6.1M60.7%Form 4, Nov 10, 2026
Amylyx Pharmaceuticals AMLX
Common Stock
Through Trust100,000$26.20$2.6M26.0%Form 4, Nov 9, 2026
Amylyx Pharmaceuticals AMLX
Common Stock
Through Trust40,000$26.20$1.0M10.4%Form 4, Nov 9, 2026
Amylyx Pharmaceuticals AMLX
Common Stock
Through Trust11,072$26.20$290K2.9%Form 4, Nov 9, 2026

Share counts are the amounts James M. Frates reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 10, 2026SoldAMLX12,800$30.32$388KView
Nov 10, 2026SoldAMLX7,200$30.97$223KView
Nov 9, 2026SoldAMLX7,700$29.39$226KView
Nov 9, 2026SoldAMLX12,300$30.11$370KView
Sep 10, 2026SoldAMLX9,768$32.27$315KView
Sep 10, 2026SoldAMLX1,042$33.23$35KView
Mar 2, 2026SoldAMLX7,909$14.52$115KView
Feb 2, 2026SoldAMLX3,557$14.65$52KView
Jan 6, 2026SoldAMLX3,326$11.11$37KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
8730Chrysostomos L. Nikias
Director, Synopsys. Mountain View, CA
$10.1M−$73K (−0.71%)
8731James Robert Foster
SVP, Finance and CFO, ATI. Dallas, TX
$10.1M−$378K (−3.61%)
8732Justin Krause
SVP FINANCE AND CONTROLLER, Sezzle. Minneapolis, MN
$10.1M−$844K (−7.72%)
8733James M. Frates
Chief Financial Officer, Amylyx Pharmaceuticals. Cambridge, MA
$10.1M−$162K (−1.58%)
8734Louis Todd Borgmann
CHIEF EXECUTIVE OFFICER, Calumet. Indianapolis, IN
$10.1M+$246K (+2.51%)
8735John F. Runkel Jr.
GC & Corporate Secretary, Synopsys. Sunnyvale, CA
$10.1M−$72K (−0.71%)
8736David A. Buzen
Head of Asset Management*, Assured Guaranty
$10.1M+$20K (+0.20%)

Other Amylyx Pharmaceuticals insiders

All AMLX insiders

Questions

How much stock does James M. Frates own?

James M. Frates holds $10,079,061 in listed stock based on SEC filings and current prices, mostly Amylyx Pharmaceuticals (AMLX). That ranks 8733rd on the Stock Rich List.

Is this James M. Frates's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did James M. Frates last buy or sell stock?

The most recent open-market trade on file is a sale of 12,800 AMLX shares on Nov 10, 2026 at $30.32.